IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
30.00
+1.40 (4.90%)
Nov 4, 2024, 4:00 PM EST - Market closed

IDEAYA Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Net Income
--112.96-58.66-49.76-34.5-41.98
Upgrade
Depreciation & Amortization
-4.013.523.031.381.25
Upgrade
Loss (Gain) From Sale of Assets
----00.01
Upgrade
Loss (Gain) From Sale of Investments
--11.55-0.71.830.56-0.48
Upgrade
Stock-Based Compensation
-18.4911.638.243.612.17
Upgrade
Change in Accounts Receivable
-0.190.890.77-1.88-
Upgrade
Change in Accounts Payable
-2.641.861.170.23-0.2
Upgrade
Change in Unearned Revenue
--13.75-46.48-23.5483.77-
Upgrade
Change in Other Net Operating Assets
--2.280.752.482.29-0.09
Upgrade
Operating Cash Flow
--115.22-87.18-55.7855.46-39.31
Upgrade
Capital Expenditures
--2.37-3.44-2.64-0.49-1.35
Upgrade
Investment in Securities
--156.09-29.96-67.02-145.753.62
Upgrade
Investing Cash Flow
--158.46-33.4-69.67-146.242.27
Upgrade
Issuance of Common Stock
-320.5497.17145.45128.7550.61
Upgrade
Other Financing Activities
-42.18----
Upgrade
Financing Cash Flow
-362.7297.17145.45128.7550.61
Upgrade
Net Cash Flow
-89.04-23.4120.0137.9713.56
Upgrade
Free Cash Flow
--117.59-90.62-58.4254.97-40.67
Upgrade
Free Cash Flow Margin
--502.85%-177.92%-209.09%281.35%-
Upgrade
Free Cash Flow Per Share
--2.04-2.19-1.662.22-3.25
Upgrade
Cash Interest Paid
-0.070.060.070.080.09
Upgrade
Cash Income Tax Paid
---000
Upgrade
Levered Free Cash Flow
--70.28-42.37-15.6411.39-27.22
Upgrade
Unlevered Free Cash Flow
--70.28-42.37-15.6411.39-27.22
Upgrade
Change in Net Working Capital
-6.3915.01-7.15-28.981.61
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.